Our comprehensive guide hospitals information helps you quickly locate a hospital anywhere in the world. Our database contains in excess of 16,000 hospitals, making it one of the best places to find information on the hospital you are searching for. To assist you with locating a hospital, you can refine your search by selecting the country in which the hospital is located and choose to search by either hospital name, city/town or state/county.

 Home>> Treanda (bendamustine hydrochloride)

Treanda (bendamustine hydrochloride)

General Information

Treanda is a rationally designed purine analog and alkylator hybrid. It damages the DNA in cancer cells, which leads to the normal path of cell death (apoptosis). It also stops cancer cells from dividing to create new cancer cells.

Treanda is specifically indicated for: 1) the treatment of chronic lymphocytic leukemia where efficacy relative to first line therapies other than chlorambucil has not been established, and 2) indolent B-cell non-Hodgkin???s lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

Treanda is supplied as a powder in a 100 mg vial to be reconstituted with sterile water for intravenous administration.

The recommended initial dose of the drug for the treatment of non-Hodgkin's lymphoma is 120 mg/m2 administered intravenously over 60 minutes on Days 1 and 2 of a 21-day cycle, up to 8 cycles. Treanda administration should be delayed in the event of a Grade 4 hematologic toxicity or clinically significant > Grade 2 non-hematologic toxicity.
Dose modifications for hematologic toxicity: reduce the dose to 90 mg/m2 on Days 1 and 2 of each cycle. If Grade 4 toxicity recurs, reduce the dose to 60 mg/m2 on Days 1 and 2 of each cycle.
Dose modifications for non-hematologic toxicity: reduce the dose to 90 mg/m2 on Days 1 and 2 of each cycle. If Grade 3 or greater toxicity recurs, reduce the dose to 60 mg/m2 on Days 1 and 2 of each cycle.

The recommended initial dose of the drug for the treatment of chronic lymphocytic leukemia is 100 mg/m2 administered intravenously over 30 minutes on Days 1 and 2 of a 28-day cycle, up to 6 cycles. Treanda administration should be delayed in the event of Grade 4 hematologic toxicity or clinically significant >Grade 2 non-hematologic toxicity.
Dose modifications for hematologic toxicity: reduce the dose to 50 mg/m2 on Days 1 and 2 of each cycle; if Grade 3 or greater toxicity recurs, reduce the dose to 25 mg/m2 on Days 1 and 2 of each cycle.
Dose modifications for non-hematologic toxicity: reduce the dose to 50 mg/m2 on Days 1 and 2 of each cycle.


Additional Information

For additional information regarding Treanda, chronic lymphocytic leukemia or non-Hodgkin's lymphoma, please visit the Treanda web page.

Clinical Results

FDA Approval

FDA approval for Treanda for the treatment of chronic lymphocytic leukemia was based on the results of an open-label, randomized, controlled multicenter trial in 301 previously-untreated patients with Binet Stage B or C (Rai Stages I - IV) CLL requiring treatment. The subjects received either Treanda at 100 mg/m2, administered intravenously over a period of 30 minutes on Days 1 and 2 or chlorambucil at 0.8 mg/kg administered orally on Days 1 and 15 of each 28-day cycle. Efficacy endpoints were objective response rate and progression-free survival. The overall response rate was 59% in the Treanda arm compared to 26% in the chlorambucil arm (p<0.0001). The median progression free survival was 18 months in the Treanda arm versus 6 months in the chlorambucil arm (p<0.0001).

FDA approval for Treanda for the treatment of non-Hodgkin's lymphoma was based on the results of a single arm study of 100 subjects with indolent B-cell NHL that had progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. All subjects received Treanda intravenously at a dose of 120 mg/m2, on Days 1 and 2 of a 21-day treatment cycle. They were treated for up to 8 cycles. Overall response rate was seen in 74 of the subjects (64.3%). The median duration of response was 9.2 months.


Mechanism of Action

Treanda contains bendamustine hydrochloride, an alkylating drug. Bendamustine is a bifunctional mechlorethamine derivative containing a purine-like benzimidazole ring. Mechlorethamine and its derivatives form electrophilic alkyl groups. These groups form covalent bonds with electron-rich nucleophilic moieties, resulting in interstrand DNA crosslinks. The bifunctional covalent linkage can lead to cell death via several pathways. Bendamustine is active against both quiescent and dividing cells. However, the exact mechanism of action of bendamustine remains unknown.


Literature References

Side effects

Adverse events associated with the use of Treanda for chronic lymphocytic leukemia may include, but are not limited to, the following:

  • pyrexia
  • nausea
  • vomiting
  • asthenia
  • fatigue
  • malaise
  • weakness
  • dry mouth
  • somnolence
  • cough
  • constipation
  • headache
  • mucosal inflammation
  • stomatitis

Adverse events associated with the use of Treanda for the treatment of non-Hodgkin's lymphoma may include, but are not limited to, the following:

  • nausea
  • fatigue
  • vomiting
  • diarrhea
  • pyrexia
  • fatigue
  • febrile neutropenia
  • pneumonia
  • hypokalemia
  • dehydration.

Treatment

Chronic lymphocytic leukemia and B-cell non-Hodgkin???s lymphoma

Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Aplenzin (bupropion hydrobromide) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Protonix (pantoprazole sodium) Delayed-Release Tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Onglyza (saxagliptin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prometrium Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Omnicef Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Letairis (ambrisentan) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prandin Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Antizol Injection Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Adderall (mixed salts of a single-entity amphetamine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Livalo (pitavastatin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Intron A (Interferon alfa-2b, recombinant) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Astepro (azelastine hydrochloride nasal spray) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prezcobix (darunavir and cobicistat) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Adempas (riociguat) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print ProAmatine (midodrine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Mircette Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print AlphaNine SD Coagulation Factor IX (Human) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rapamune (sirolimus) oral solution Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Zithromax (azithromycin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print UVADEX Sterile Solution Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Naprelan (naproxen sodium) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prograf Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Akynzeo (netupitant and palonosetron) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Omontys (peginesatide) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print OxyContin (oxycodone HCl controlled-release) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Vpriv (velaglucerase alfa for injection) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Ortho Evra Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prevpac Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Betapace AF Tablet Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prilosec (omeprazole)/Biaxin (clarithromycin) Combination Therapy Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Bexxar Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Arzerra (ofatumumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print laViv (azficel-T) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Amrix (cyclobenzaprine hydrochloride extended release) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Anoro Ellipta (umeclidinium and vilanterol inhalation powder) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Cenestin Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Plenaxis (abarelix for injectable suspension) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Xyzal (levocetirizine dihydrochloride)